Pulse Biosciences, Inc.
PLSE
$17.19
$0.704.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.46% | 61.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.94% | 48.38% | |||
| Operating Income | 10.94% | -48.38% | |||
| Income Before Tax | 13.36% | -52.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.36% | -52.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.36% | -52.88% | |||
| EBIT | 10.94% | -48.38% | |||
| EBITDA | 11.08% | -49.49% | |||
| EPS Basic | 19.91% | -50.48% | |||
| Normalized Basic EPS | 19.88% | -50.39% | |||
| EPS Diluted | 19.91% | -50.48% | |||
| Normalized Diluted EPS | 19.88% | -50.39% | |||
| Average Basic Shares Outstanding | 8.17% | 1.62% | |||
| Average Diluted Shares Outstanding | 8.17% | 1.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||